Tigan is a Intramuscular Injection in the Human Prescription Drug category. It is labeled and distributed by Henry Schein, Inc. The primary component is Trimethobenzamide Hydrochloride.
| Product ID | 0404-9964_41ed5bd3-dc7d-4681-8dda-a414846fcb7c |
| NDC | 0404-9964 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Tigan |
| Generic Name | Trimethobenzamide Hydrochloride |
| Dosage Form | Injection |
| Route of Administration | INTRAMUSCULAR |
| Marketing Start Date | 2022-01-11 |
| Marketing Category | NDA / |
| Application Number | NDA017530 |
| Labeler Name | Henry Schein, Inc |
| Substance Name | TRIMETHOBENZAMIDE HYDROCHLORIDE |
| Active Ingredient Strength | 100 mg/mL |
| Pharm Classes | Antiemetic [EPC],Emesis Suppression [PE] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2022-01-11 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0404-9964 | Tigan | Trimethobenzamide Hydrochloride |
| 21695-853 | Tigan | trimethobenzamide hydrochloride |
| 42023-118 | Tigan | trimethobenzamide hydrochloride |
| 42023-119 | Tigan | trimethobenzamide hydrochloride |
| 52584-119 | Tigan | Trimethobenzamide Hydrochloride |
| 61570-079 | TIGAN | trimethobenzamide hydrochloride |
| 70518-1225 | TIGAN | trimethobenzamide hydrochloride |
| 43386-660 | Trimethobenzamide Hydrochloride | Trimethobenzamide Hydrochloride |
| 50090-2122 | Trimethobenzamide Hydrochloride | Trimethobenzamide Hydrochloride |
| 53489-376 | Trimethobenzamide Hydrochloride | Trimethobenzamide Hydrochloride |
| 63629-3685 | Trimethobenzamide Hydrochloride | Trimethobenzamide Hydrochloride |
| 70518-0510 | Trimethobenzamide Hydrochloride | Trimethobenzamide Hydrochloride |
| 71335-0800 | Trimethobenzamide Hydrochloride | Trimethobenzamide Hydrochloride |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() TIGAN 72064174 0684353 Live/Registered |
HOFFMANN-LA ROCHE INC. 1958-12-12 |